A personalized mRNA vaccine, combined with the drug Keytruda, may help prevent skin cancer (melanoma) from returning after surgery. This is suggested by a large clinical trial. The treatment aims to strengthen the body's defense against cancer.
This article was AI-summarized from Sciencenews.org. Read original on Sciencenews.org